HER2 Positive Breast Cancer

Book HER2 Positive Breast Cancer Cover

Read or download book entitled HER2 Positive Breast Cancer written by Sara Hurvitz and published by Elsevier Health Sciences in PDF, EPUB and Kindle Format. Click Get This Book button to download or read online books. Join over 650.000 happy Readers and READ as many books as you like. We cannot guarantee that HER2 Positive Breast Cancer book is available in the library.

  • Publisher : Elsevier Health Sciences
  • Release : 26 July 2018
  • ISBN : 9780323581233
  • Page : 264 pages
  • Rating : 4.5/5 from 103 voters

Download HER2 Positive Breast Cancer in PDF, Epub and Kindle

Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today’s available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists.

GET THIS BOOK

HER2-Positive Breast Cancer

HER2-Positive Breast Cancer
  • Author : Sara Hurvitz,Kelly McCann
  • Publisher : Elsevier Health Sciences
  • Release Date : 2018-07-26
  • ISBN : 9780323581233
GET THIS BOOKHER2-Positive Breast Cancer

Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today’s available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists.

Targeted Therapies in Breast Cancer

Targeted Therapies in Breast Cancer
  • Author : George W. Sledge, Jr.,Jose Baselga
  • Publisher : Unknown
  • Release Date : 2013-04-15
  • ISBN : 1846920663
GET THIS BOOKTargeted Therapies in Breast Cancer

This new volume updates the reader on selected areas of targeted therapy in breast cancer, with special emphasis on chemoprevention strategies, drug resistance, biomarkers, combination chemotherapy, angiogenesis inhibition and pharmacogenomics in the context of clinical efficacy. This selected review of targeted therapies will guide the reader on effective treatment as part of an integrated programme of patient management.

Central Nervous System Metastases

Central Nervous System Metastases
  • Author : Manmeet Ahluwalia,Philippe Metellus,Riccardo Soffietti
  • Publisher : Springer Nature
  • Release Date : 2019-11-05
  • ISBN : 9783030234171
GET THIS BOOKCentral Nervous System Metastases

This book provides a comprehensive overview of brain metastases, from the molecular biology aspects to therapeutic management and perspectives. Due to the increasing incidence of these tumors and the urgent need to effectively control brain metastatic diseases in these patients, new therapeutic strategies have emerged in recent years. The volume discusses all these innovative approaches combined with new surgical techniques (fluorescence, functional mapping, integrated navigation), novel radiation therapy techniques (stereotactic radiosurgery) and new systemic treatment approaches such as targeted- and

Her-2

Her-2
  • Author : Robert Bazell
  • Publisher : Random House
  • Release Date : 2011-04-27
  • ISBN : 9780307764980
GET THIS BOOKHer-2

Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield's aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech's clinical trials for a new drug. Five years later she remains cancer-free. Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation,

Take Control of Your Cancer Risk

Take Control of Your Cancer Risk
  • Author : John Whyte, MD, MPH
  • Publisher : Harper Horizon
  • Release Date : 2021-10-05
  • ISBN : 9780785240419
GET THIS BOOKTake Control of Your Cancer Risk

Something everyone has the power to do is reduce your cancer risk, and this book will show you just how easy it is to do it. Each year, over a million people in the United States alone hear the words no one ever wants to hear: You have cancer. But what if there was a way for fewer people to hear these words? One of the biggest myths regarding cancer is that it’s mostly genetic - meaning that you

Abeloff's Clinical Oncology E-Book

Abeloff's Clinical Oncology E-Book
  • Author : Martin D. Abeloff,James O. Armitage,John E. Niederhuber,Michael B. Kastan,W. Gillies McKenna
  • Publisher : Elsevier Health Sciences
  • Release Date : 2008-06-30
  • ISBN : 9781437720563
GET THIS BOOKAbeloff's Clinical Oncology E-Book

Carrying on the tradition established by its founding editor, the late Dr. Martin Abeloff, the 4th Edition of this respected reference synthesizes all of the latest oncology knowledge in one practical, clinically focused, easy-to-use volume. It incorporates basic science, pathology, diagnosis, management, outcomes, rehabilitation, and prevention – all in one convenient resource – equipping you to overcome your toughest clinical challenges. What's more, you can access the complete contents of this Expert Consult title online, and tap into its unparalleled guidance wherever

Sentinel Lymph Node Biopsy

Sentinel Lymph Node Biopsy
  • Author : Hiram S. Cody
  • Publisher : CRC Press
  • Release Date : 2001-11-08
  • ISBN : 1841840343
GET THIS BOOKSentinel Lymph Node Biopsy

An intuitive, ingenious and powerful technique, sentinel lymph node biopsy has entered clinical practice with astonishing rapidity and now represents a new standard of care for melanoma and breast cancer patients, while showing great promise for the treatment of urologic, colorectal, gynecologic, and head and neck cancers. This text, written by international experts in the technique, provides a clear and comprehensive guide, presenting a detailed overview and discussing the various mapping techniques available and how these are applied in a

Handbook of HER2-Targeted Agents in Breast Cancer

Handbook of HER2-Targeted Agents in Breast Cancer
  • Author : Ricardo H Alvarez,Javier Cortés,Mary Falzon,Michael Gandy,Luca Gianni,Nadia Harbeck,Martine Piccart
  • Publisher : Springer
  • Release Date : 2016-05-14
  • ISBN : 9783319282169
GET THIS BOOKHandbook of HER2-Targeted Agents in Breast Cancer

This concise handbook provides oncologists and other healthcare providers with crucial updates in the field, including an updated review of the current understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based discussions of available and emerging HER2-targeted treatment options. An essential clinical text for physicians that screen and treat patients with breast cancer and require an accessible, up-to-date survey of the dynamic treatment landscape.

Treatment of HER2-positive Breast Cancer

Treatment of HER2-positive Breast Cancer
  • Author : Simona Borštnar
  • Publisher : Unknown
  • Release Date : 2015
  • ISBN : OCLC:911528857
GET THIS BOOKTreatment of HER2-positive Breast Cancer

Preoperative (Neoadjuvant) Chemotherapy

Preoperative (Neoadjuvant) Chemotherapy
  • Author : Joseph Ragaz,Pierre R. Band,James H. Goldie
  • Publisher : Springer Science & Business Media
  • Release Date : 2012-12-06
  • ISBN : 9783642826719
GET THIS BOOKPreoperative (Neoadjuvant) Chemotherapy

Despite recent advances in adjuvant therapies of cancer, the regi mens of postoperative adjuvant chemotherapy treatment which are presently available fail to cure the majority of cancer patients. Pre operative (neoadjuvant) chemotherapy represents a new approach in drug scheduling, based on sound theoretical, pharmacokinetic, and experimental principles. The preoperative timing of chemotherapy before definitive sur gery is not a minor change in the therapy of cancer. To be successful, large numbers of practitioners and their patients must participate. Substantial alterations

Handbook of HER2-targeted agents in breast cancer

Handbook of HER2-targeted agents in breast cancer
  • Author : Ricardo H Alvarez,Javier Cortés,Leticia Mattos-Arruda,Mary Falzon,Angelica Fasolo,Michael Gandy,Luca Gianni,Nadia Harbeck,Martine Piccart,Stefania Zambelli,Dimitrios Zardavas
  • Publisher : Springer
  • Release Date : 2014-05-28
  • ISBN : 9781907673948
GET THIS BOOKHandbook of HER2-targeted agents in breast cancer

​Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women worldwide, accounting for nearly a quarter of the total new cancer cases each year. Of these cases, approximately 15–25% overexpress HER2, a transmembrane RTK kinase that is associated with aggressive tumor growth and poor outcomes. However, in the past decade, survival rates of patients with HER-positive breast cancer have significantly improved due to increased screening, HER2 testing, and breakthrough HER2-targeted drug therapies. Handbook

Neo-adjuvant Chemotherapy

Neo-adjuvant Chemotherapy
  • Author : Claude Jacquillat,Marise Weil,David Khayat,Institut national de la santé et de la recherche médicale (France)
  • Publisher : John Libbey Eurotext
  • Release Date : 1988
  • ISBN : 0861961501
GET THIS BOOKNeo-adjuvant Chemotherapy

This book presents the Proceedings of the Second International Congress on Neo-Adjuvant Chemotherapy which took place on 19 to 21 February 1988 in Paris.

Breast Cancer

Breast Cancer
  • Author : Phuc Van Pham
  • Publisher : BoD – Books on Demand
  • Release Date : 2017-04-05
  • ISBN : 9789535129998
GET THIS BOOKBreast Cancer

Breast Cancer - From Biology to Medicine thoroughly examines breast cancer from basic definitions, to cellular and molecular biology, to diagnosis and treatment. This book also has some additional focus on preclinical and clinical results in diagnosis and treatment of breast cancer. The book begins with introduction on epidemiology and pathophysiology of breast cancer in Section 1. In Section 2, the subsequent chapters introduce molecular and cellular biology of breast cancer with some particular signaling pathways, the gene expression, as well as

HER2 Testing to Manage Patients with Breast Cancer and Other Solid Tumors

HER2 Testing to Manage Patients with Breast Cancer and Other Solid Tumors
  • Author : U. S. Department of Health and Human Services,Agency for Healthcare Research and Quality
  • Publisher : Createspace Independent Pub
  • Release Date : 2013-05-31
  • ISBN : 1490324178
GET THIS BOOKHER2 Testing to Manage Patients with Breast Cancer and Other Solid Tumors

The human epidermal growth factor receptor-2 (HER2) gene is amplified and the HER2 protein overexpressed in approximately 18–20 percent of breast cancer cases. Amplification or overexpression of HER2 is associated with poor prognosis. Evidence from randomized trials demonstrates that adding trastuzumab, a therapeutic monoclonal antibody that targets HER2, to adjuvant chemotherapy regimens for HER2-positive breast cancer improves survival. HER2 also is overexpressed in other epithelial malignancies such as ovarian, thyroid, lung, salivary gland/head and neck, stomach, colon, and prostate

“Understanding the Role of Human epidermal growth factor receptor 2 (HER2) in various Cancers and its Therapeutic Implications.’’

“Understanding the Role of Human epidermal growth factor receptor 2 (HER2) in various Cancers and its Therapeutic Implications.’’
  • Author : Dr. Hakim Saboowala
  • Publisher : Dr.Hakim Saboowala
  • Release Date : 2019-08-06
  • ISBN : 0987654321XXX
GET THIS BOOK“Understanding the Role of Human epidermal growth factor receptor 2 (HER2) in various Cancers and its Therapeutic Implications.’’

The human epidermal growth factor receptor (HER) family of receptors plays a central role in the pathogenesis of several human cancers. · It is a member of the epidermal growth factor receptor family having tyrosine kinase activity. Dimerization of the receptor results in the autophosphorylation of tyrosine residues within the cytoplasmic domain of the receptors and initiates a variety of signaling pathways leading to cell proliferation and tumorigenesis. Amplification or overexpression of HER2 occurs in approximately 15–30% of breast cancers and 10–30% of